Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Research and Markets Releases COVID 19 Clinical Trials Insight | Contract Pharma
Breaking News, Trials & Filings

Research and Markets Releases COVID 19 Clinical Trials Insight

More than 30 clinical trials are being conducted at the global level, with hundreds of patients enrolled

Research and Markets has added The “Global Coronavirus COVID 19 Clinical Trials Insight 2020” to its reporting.

Number of Drugs in Clinical Trials: >30 Drugs
Majority of Drugs in Research Phase: >15 Drugs
USA & China Dominating Clinical Trials: >20 Drugs
Vaccines Accounts Major Share in Clinical Trials: >10 Vaccines
Expected Market Opportunity: >U.S. $ 1 Billion

Since the recent outbreak of the virus at the global level, research fields at all levels have focused their work on developing a vaccine that will be effective against the mechanism of the coronavirus by which it is escaping all the commercially available vaccines for virus.

On an average, more than 30 clinical trials are being conducted at the global level, with hundreds of patients enrolled. Of the 30 clinical trials that have been initiated, only few have cleared the early stages of development, with a few set to begin Phase III trials.

The outbreak of the virus has led advancement in the partnership for technological support. By observing the number of the patients and the healthcare management all the world, it is expected that the very first therapy against the virus will be launched by next year in 2021.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters